Lupin gets US FDA approval for dimethyl fumarate delayed release capsules EP News Bureau Oct 6, 2020 According to IQVIA MAT June 2020 data, dimethyl fumarate delayed-release capsules had an annual sales of approximately USD 3788…
Mylan announces launch of generic version of Biogen’s Tecfidera EP News Bureau Aug 20, 2020 Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
Glenmark receives ANDA approval for Dimethyl Fumarate Delayed-Release capsules EP News Bureau Oct 9, 2019 The drug is indicated to treat relapsing forms of multiple sclerosis Glenmark Pharmaceuticals has been granted tentative…
